BridgeBio Oncology Therapeutics, Inc. (BBOT) Form 10-Q Quarterly Reports
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BBOT
CIK: 1869105
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerMay Yu
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-05 | 2026-10-01 | 4 | 0001193125-26-414135 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | 4 | 0001193125-26-414131 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | 4 | 0001193125-26-414127 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | 4 | 0001193125-26-414123 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390624 | View SEC Doc Filr Page |
| EFFECT | 2026-09-10 | — | EFFECT Filing | 9999999995-26-002939 | View SEC Doc Filr Page |
| EFFECT | 2026-09-08 | — | EFFECT Filing | 9999999995-26-002909 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | 8-K | 0001193125-26-385225 | View SEC Doc Filr Page |
| S-3 | 2026-09-01 | — | S-3 | 0001193125-26-378637 | View SEC Doc Filr Page |
| POS AM | 2026-09-01 | — | POS AM | 0001193125-26-378366 | View SEC Doc Filr Page |
| 424B3 | 2026-08-12 | — | 424B3 | 0001193125-26-345123 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-344661 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-344608 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001193125-26-296504 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001193125-26-296503 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001193125-26-296502 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 | 0001193125-26-296501 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-06 | — | SCHEDULE 13D/A Filing | 0001213900-26-075546 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2026-07-01 | 4 Filing | 0001213900-26-075538 | View SEC Doc Filr Page |
| 424B3 | 2026-06-22 | — | 424B3 | 0001193125-26-277572 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-16 | 8-K | 0001193125-26-277513 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001193125-26-276050 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001193125-26-276048 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001193125-26-276046 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | 4 | 0001193125-26-276043 | View SEC Doc Filr Page |